SEC Tracker
Get the app

Actuate Therapeutics ACTU

Actuate Therapeutics: Securities offering (amended)

Securities offering (amended)

Form
S-1/A
Filed
Importance
Routine
  1. 40,000,000 shares of common stock offered
  2. 20,000,000 purchase warrants offered
  3. Warrants exercisable at $ per share
  4. Offering includes shares from warrant exercises

Written from the S-1/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Actuate Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Lite Strategy LITS public float $43M, Dec 31, 2025
  2. Actinium Pharmaceuticals ATNM public float $44M, Jun 30, 2025
  3. Fortress Biotech FBIO public float $44M, Jun 30, 2025
  4. CervoMed CRVO public float $40M, Jun 30, 2025
  5. Acumen Pharmaceuticals ABOS public float $45M, Jun 30, 2025